These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 25893131)

  • 1. A Pharmacokinetic Study of Antimalarial 3,5-Diaryl-2-aminopyridine Derivatives.
    Dambuza N; Smith P; Evans A; Taylor D; Chibale K; Wiesner L
    Malar Res Treat; 2015; 2015():405962. PubMed ID: 25893131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and pharmacokinetic evaluation of a novel anti-malarial compound (NP046) in a mouse model.
    Abay ET; van der Westuizen JH; Swart KJ; Gibhard L; Lawrence N; Dambuza N; Wilhelm A; Pravin K; Wiesner L
    Malar J; 2015 Jan; 14():8. PubMed ID: 25563929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiplasmodial activity, in vivo pharmacokinetics and anti-malarial efficacy evaluation of hydroxypyridinone hybrids in a mouse model.
    Dambuza NS; Smith P; Evans A; Norman J; Taylor D; Andayi A; Egan T; Chibale K; Wiesner L
    Malar J; 2015 Dec; 14():505. PubMed ID: 26671222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic evaluation of Chalcone derivatives with antimalarial activity in New Zealand White Rabbits.
    Sinha S; Prakash A; Medhi B; Sehgal A; Batovska DI; Sehgal R
    BMC Res Notes; 2021 Jul; 14(1):264. PubMed ID: 34238361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety, tolerability, pharmacokinetics, and antimalarial efficacy of a novel Plasmodium falciparum ATP4 inhibitor SJ733: a first-in-human and induced blood-stage malaria phase 1a/b trial.
    Gaur AH; McCarthy JS; Panetta JC; Dallas RH; Woodford J; Tang L; Smith AM; Stewart TB; Branum KC; Freeman BB; Patel ND; John E; Chalon S; Ost S; Heine RN; Richardson JL; Christensen R; Flynn PM; Van Gessel Y; Mitasev B; Möhrle JJ; Gusovsky F; Bebrevska L; Guy RK
    Lancet Infect Dis; 2020 Aug; 20(8):964-975. PubMed ID: 32275867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-activity relationship studies of orally active antimalarial 3,5-substituted 2-aminopyridines.
    González Cabrera D; Douelle F; Younis Y; Feng TS; Le Manach C; Nchinda AT; Street LJ; Scheurer C; Kamber J; White KL; Montagnat OD; Ryan E; Katneni K; Zabiulla KM; Joseph JT; Bashyam S; Waterson D; Witty MJ; Charman SA; Wittlin S; Chibale K
    J Med Chem; 2012 Dec; 55(24):11022-30. PubMed ID: 23189922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3,5-Diaryl-2-aminopyridines as a novel class of orally active antimalarials demonstrating single dose cure in mice and clinical candidate potential.
    Younis Y; Douelle F; Feng TS; González Cabrera D; Le Manach C; Nchinda AT; Duffy S; White KL; Shackleford DM; Morizzi J; Mannila J; Katneni K; Bhamidipati R; Zabiulla KM; Joseph JT; Bashyam S; Waterson D; Witty MJ; Hardick D; Wittlin S; Avery V; Charman SA; Chibale K
    J Med Chem; 2012 Apr; 55(7):3479-87. PubMed ID: 22390538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In Vitro and In Vivo Pharmacokinetics of Aminoalkylated Diarylpropanes NP085 and NP102.
    Gibhard L; Pravin K; Abay E; Wilhelm A; Swart K; Lawrence N; Khoury R; van der Westhuizen J; Smith P; Wiesner L
    Antimicrob Agents Chemother; 2016 May; 60(5):3065-9. PubMed ID: 26953201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malaria Surveillance - United States, 2015.
    Mace KE; Arguin PM; Tan KR
    MMWR Surveill Summ; 2018 May; 67(7):1-28. PubMed ID: 29723168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malaria Surveillance - United States, 2016.
    Mace KE; Arguin PM; Lucchi NW; Tan KR
    MMWR Surveill Summ; 2019 May; 68(5):1-35. PubMed ID: 31099769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New quinoline derivatives demonstrate a promising antimalarial activity against Plasmodium falciparum in vitro and Plasmodium berghei in vivo.
    Soares RR; da Silva JM; Carlos BC; da Fonseca CC; de Souza LS; Lopes FV; de Paula Dias RM; Moreira PO; Abramo C; Viana GH; de Pila Varotti F; da Silva AD; Scopel KK
    Bioorg Med Chem Lett; 2015 Jun; 25(11):2308-13. PubMed ID: 25920564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malaria Surveillance - United States, 2014.
    Mace KE; Arguin PM
    MMWR Surveill Summ; 2017 May; 66(12):1-24. PubMed ID: 28542123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological properties of a new antimalarial bisthiazolium salt, T3, and a corresponding prodrug, TE3.
    Nicolas O; Margout D; Taudon N; Wein S; Calas M; Vial HJ; Bressolle FM
    Antimicrob Agents Chemother; 2005 Sep; 49(9):3631-9. PubMed ID: 16127032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mefloquine. A review of its antimalarial activity, pharmacokinetic properties and therapeutic efficacy.
    Palmer KJ; Holliday SM; Brogden RN
    Drugs; 1993 Mar; 45(3):430-75. PubMed ID: 7682911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malaria Surveillance - United States, 2013.
    Cullen KA; Mace KE; Arguin PM;
    MMWR Surveill Summ; 2016 Mar; 65(2):1-22. PubMed ID: 26938139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasmodium falciparum Resistance to a Lead Benzoxaborole Due to Blocked Compound Activation and Altered Ubiquitination or Sumoylation.
    Sindhe KMV; Wu W; Legac J; Zhang YK; Easom EE; Cooper RA; Plattner JJ; Freund YR; DeRisi JL; Rosenthal PJ
    mBio; 2020 Jan; 11(1):. PubMed ID: 31992618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malaria surveillance--United States, 2012.
    Cullen KA; Arguin PM;
    MMWR Surveill Summ; 2014 Dec; 63(12):1-22. PubMed ID: 25474160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of pyridyl thiosemicarbazones as highly potent agents for the treatment of malaria after oral administration.
    Parkinson CJ; Birrell GW; Chavchich M; Mackenzie D; Haynes RK; de Kock C; Richardson DR; Edstein MD
    J Antimicrob Chemother; 2019 Oct; 74(10):2965-2973. PubMed ID: 31325302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. UK malaria treatment guidelines.
    Lalloo DG; Shingadia D; Pasvol G; Chiodini PL; Whitty CJ; Beeching NJ; Hill DR; Warrell DA; Bannister BA;
    J Infect; 2007 Feb; 54(2):111-21. PubMed ID: 17215045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. β-Carboline Derivatives Tackling Malaria: Biological Evaluation and Docking Analysis.
    Gorki V; Walter NS; Singh R; Chauhan M; Dhingra N; Salunke DB; Kaur S
    ACS Omega; 2020 Jul; 5(29):17993-18006. PubMed ID: 32743172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.